Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Case report  

Topical treatment with BGP-15M, a poly(ADP-ribose) polymerase inhibitor protects from ultraviolet radiation-induced skin cancer in vivo

B. Farkas, M. Magyarlaki, B. Csete, S. Bernath

Med Sci Monit 2003; 9(1): 25-0 :: ID: 15075

Abstract

Experimental data suggest that enzymes and substances, which decrease DNA-damage or improve repair can be used as photoprotective agents. These observations have led to the development of new strategies to facilitate DNA-repair in human cells and thereby improve photoprotection [1–3]. UV-irradiation may have deleterious effects on the DNA of skin cells. Indeed, UV-irradiation is capable of inducing extensive DNA-damage that overactivates PARP causing increased energy demand, which in turn may result in collapse of energy metabolism and in cell death. This suggests that moderation of PARP activity following DNA-damage may protect skin cells from the harmful effects of acute and chronic UV-exposure.The effects of BGP-15M, a topically applied novel PARP-inhibitor on UV-induced acute and chronic photodamage were investigated in a hairless mouse model and in human skin. DNA injury was detected by measuring the formation of single-strand DNA breaks and counting sunburn cells. The ADP-ribosylation of PARP was assessed by Western blot analysis. Immunosuppression was investigated in epidermal cells by detecting TNFá and IL-10 expression. UV-induced photocarcinogenesis was determined by clinical, immunohistochemical, and biochemical methods. It has been observed that BGP-15M protects against the clinical and histopathological signs of long-term (26 week) UVA exposure in 8-methoxipsoralen sensitized skin, and decreases the UVB-induced accumulation of mutations and deletions in tumor suppressor genes. Topical treatment with BGP-15M prevents photocarcinogenesis induced by long-term, 32 week-UVB or 26 week-UVA exposure in hairless mice. The above observations carry the promise of a novel type biological skin protective agent against UV-induced photocarcinogenesis, which can revolutionize sun protection in the coming years. References: 1.Yarosh D et al: Lancet, 2001; 357: 926 2.Farkas B et al: Biochem Pharmacol, 2002; 63: 921 3.Farkas B et al: Pharmacology & Toxicology Series, Boca Raton, London, Washington, CRC Press 2002; pp: 257

Keywords: topical PARP-inhibitor, skin cancer, UVA, UVB, photoprotection

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological Surgery

Med Sci Monit In Press; DOI: 10.12659/MSM.947088  

0:00

Review article  

Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention

Med Sci Monit In Press; DOI: 10.12659/MSM.947173  

0:00

Clinical Research  

Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelome...

Med Sci Monit In Press; DOI: 10.12659/MSM.947873  

0:00

Clinical Research  

Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis Patients

Med Sci Monit In Press; DOI: 10.12659/MSM.947630  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,932,897

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,919

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   29,882

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   23,844

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750